Prostate Cancer Program

Program Leaders

Matt Cooperberg, MD
Matthew Cooperberg, MD, MPH
Felix Feng, MD
Felix Feng, MD
Eric Small, MD
Eric J. Small, MD
Education and Training Liaison: Sima Porten, MD, MPH
Community Engagement Liaison: Samuel Washington III, MD, MAS

The overarching scientific goal of the Prostate Cancer Program is to use a team approach to advance the understanding of tumor biology and drive translation into more effective and targeted treatment. This is done through translational research spanning discovery bench science to clinical application and back. The program also seeks to address the burden of prostate cancer and disparities in outcomes among patients within the catchment area.

The goals of the Prostate Cancer Program are addressed through research, education and training, and community engagement aligned under the following aims:

  • Aim 1: To discover the biologic and molecular drivers of prostate cancer
  • Aim 2: To develop biomarkers and prognostic models to predict outcomes in men with prostate cancer
  • Aim 3: To develop clinical interventions to improve outcomes for men with prostate cancer
Members

Roster of Prostate Cancer Program

Total: 52 members.

For details on membership criteria, please see our membership page.